Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.8892 USD
−19.51 M USD
0.00 USD
13.79 M
About Imunon, Inc.
Sector
Industry
CEO
Stacy R. Lindborg
Website
Headquarters
Lawrenceville
Founded
1982
FIGI
BBG000BJJGT8
Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IMNN is 0.6930 USD — it has increased by 1.32% in the past 24 hours. Watch Imunon, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Imunon, Inc. stocks are traded under the ticker IMNN.
IMNN stock has fallen by −11.15% compared to the previous week, the month change is a −30.00% fall, over the last year Imunon, Inc. has showed a −23.00% decrease.
We've gathered analysts' opinions on Imunon, Inc. future price: according to them, IMNN price has a max estimate of 29.00 USD and a min estimate of 5.00 USD. Watch IMNN chart and read a more detailed Imunon, Inc. stock forecast: see what analysts think of Imunon, Inc. and suggest that you do with its stocks.
IMNN reached its all-time high on Mar 3, 2000 with the price of 145,279.1916 USD, and its all-time low was 0.4800 USD and was reached on Feb 12, 2024. View more price dynamics on IMNN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
IMNN stock is 9.16% volatile and has beta coefficient of 1.91. Track Imunon, Inc. stock price on the chart and check out the list of the most volatile stocks — is Imunon, Inc. there?
Today Imunon, Inc. has the market capitalization of 10.05 M, it has decreased by −8.56% over the last week.
Yes, you can track Imunon, Inc. financials in yearly and quarterly reports right on TradingView.
Imunon, Inc. is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
IMNN earnings for the last quarter are −0.34 USD per share, whereas the estimation was −0.39 USD resulting in a 12.37% surprise. The estimated earnings for the next quarter are −0.36 USD per share. See more details about Imunon, Inc. earnings.
Imunon, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
IMNN net income for the last quarter is −4.85 M USD, while the quarter before that showed −4.79 M USD of net income which accounts for −1.20% change. Track more Imunon, Inc. financial stats to get the full picture.
No, IMNN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 33.00 employees. See our rating of the largest employees — is Imunon, Inc. on this list?
Like other stocks, IMNN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Imunon, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Imunon, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Imunon, Inc. stock shows the strong sell signal. See more of Imunon, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.